<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Caeruloplasmin (Cp) concentration and oxidase activity have been shown to be elevated in <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (RA) and psoriatic <z:hpo ids='HP_0001369'>arthritis</z:hpo>, but <z:mpath ids='MPATH_458'>normal</z:mpath> in <z:e sem="disease" ids="C0035012" disease_type="Disease or Syndrome" abbrv="">Reiter's syndrome</z:e>, <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's syndrome</z:e> and <z:e sem="disease" ids="C1444840" disease_type="Disease or Syndrome" abbrv="">juvenile seronegative polyarthritis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Synovial fluid Cp was significantly depressed in comparison with serum Cp in RA </plain></SENT>
<SENT sid="2" pm="."><plain>During second-line therapy in RA, Cp concentration and activity fell significantly (P less than 0.001), but the change in Cp did not correlate with plasma viscosity </plain></SENT>
</text></document>